Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1 Buy
+1
New +$1 ﹤0.01% 5669
2026
Q1
Sell
-31,400
Closed -$42.4K 6462
2025
Q4
$42.4K Buy
+31,400
New +$31.6K ﹤0.01% 4634
2020
Q2
Sell
-6
Closed -$2K 7700
2020
Q1
$2K Hold
6
﹤0.01% 7449
2019
Q4
$5K Buy
6
+5
+500% +$6K ﹤0.01% 7408
2019
Q3
$1K Sell
1
-6
-86% -$9.62K ﹤0.01% 7637
2019
Q2
$14K Buy
+7
New +$14.2K ﹤0.01% 7212

Other funds holding YCBD

Citigroup's YCBD Position: Q2 2026 in Review

Citigroup opened a new position in cbdMD (YCBD) in Q2 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #5669 among its holdings. This is a return to the name: Citigroup previously reported a position in YCBD as recently as Q4 2025.

Citigroup first reported a position in YCBD in Q2 2019 and has held it in 6 quarters since. The position peaked at $42.4K in Q4 2025. 27 funds tracked by Wall St. Rank hold YCBD as of Q2 2026.

  • Citigroup held 1 share of cbdMD worth $1 as of Q2 2026.
  • cbdMD was a new Citigroup position in Q2 2026.
  • cbdMD made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5669 holding.
  • Citigroup first reported a position in cbdMD in Q2 2019 and has held it in 6 quarters since.
  • Citigroup's cbdMD position peaked at $42.4K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held cbdMD as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.